Literature DB >> 7948267

Long-term effects of peritoneal dialysis on peritoneal morphology.

J W Dobbie1, J D Anderson, C Hind.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7948267

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  8 in total

1.  Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells.

Authors:  T Rampino; G Cancarini; M Gregorini; P Guallini; M Maggio; A Ranghino; G Soccio; A Dal Canton
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit.

Authors:  Yuuki Ro; Chieko Hamada; Hiroaki Io; Kayo Hayashi; Ichiro Hirahara; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 3.  Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

4.  Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.

Authors:  David W Johnson; Margaret Clarke; Vanessa Wilson; Feidhlim Woods; Fiona G Brown
Journal:  BMC Nephrol       Date:  2010-09-16       Impact factor: 2.388

5.  Monitoring of the peritoneal membrane.

Authors:  Dirk G Struijk
Journal:  NDT Plus       Date:  2008-10

6.  A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients.

Authors:  Che-Yi Chou; Chin-Chung Tseng; Jin-Bor Chen; Chin-Chuan Hung; Chiu-Ching Huang
Journal:  Biomed Res Int       Date:  2021-01-18       Impact factor: 3.411

7.  The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.

Authors:  David W Johnson; Fiona G Brown; Margaret Clarke; Neil Boudville; Tony J Elias; Marjorie W Y Foo; Bernard Jones; Hemant Kulkarni; Robyn Langham; Dwarakanathan Ranganathan; John Schollum; Michael G Suranyi; Seng H Tan; David Voss
Journal:  Nephrol Dial Transplant       Date:  2012-08-01       Impact factor: 5.992

8.  BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].

Authors:  Barbara Nau; Claus P Schmitt; Margarida Almeida; Klaus Arbeiter; Gianluigi Ardissino; Klaus E Bonzel; Alberto Edefonti; Michel Fischbach; Karin Haluany; Joachim Misselwitz; Markus J Kemper; Kai Rönnholm; Simone Wygoda; Franz Schaefer
Journal:  BMC Nephrol       Date:  2004-10-14       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.